| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | ruffle assembly | 2.76e-04 | 47 | 11 | 2 | GO:0097178 | |
| GeneOntologyBiologicalProcess | ruffle organization | 4.65e-04 | 61 | 11 | 2 | GO:0031529 | |
| GeneOntologyBiologicalProcess | protein alkylation | 5.44e-04 | 66 | 11 | 2 | GO:0008213 | |
| GeneOntologyBiologicalProcess | protein methylation | 5.44e-04 | 66 | 11 | 2 | GO:0006479 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 7.36e-04 | 846 | 11 | 4 | GO:0120035 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 7.93e-04 | 863 | 11 | 4 | GO:0031344 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.72e-03 | 109 | 12 | 2 | GO:0005796 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.01e-03 | 530 | 12 | 3 | GO:0062023 | |
| GeneOntologyCellularComponent | vacuolar lumen | 4.50e-03 | 178 | 12 | 2 | GO:0005775 | |
| GeneOntologyCellularComponent | extracellular matrix | 5.48e-03 | 656 | 12 | 3 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 5.52e-03 | 658 | 12 | 3 | GO:0030312 | |
| HumanPheno | Spastic paraplegia | 5.32e-04 | 118 | 2 | 2 | HP:0001258 | |
| HumanPheno | Paraplegia | 8.73e-04 | 151 | 2 | 2 | HP:0010550 | |
| Domain | zf-RING_2 | 4.93e-04 | 52 | 12 | 2 | PF13639 | |
| Domain | - | 9.70e-04 | 73 | 12 | 2 | 2.60.120.260 | |
| Domain | Galactose-bd-like | 1.60e-03 | 94 | 12 | 2 | IPR008979 | |
| Domain | Ig_E-set | 1.95e-03 | 104 | 12 | 2 | IPR014756 | |
| Domain | ZF_RING_1 | 1.44e-02 | 291 | 12 | 2 | PS00518 | |
| Domain | ZF_RING_2 | 1.51e-02 | 298 | 12 | 2 | PS50089 | |
| Domain | RING | 1.57e-02 | 305 | 12 | 2 | SM00184 | |
| Domain | Znf_RING | 1.79e-02 | 326 | 12 | 2 | IPR001841 | |
| Domain | - | 3.25e-02 | 449 | 12 | 2 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 3.38e-02 | 459 | 12 | 2 | IPR013083 | |
| Pubmed | 1.70e-08 | 260 | 12 | 5 | 36199071 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 2.08e-07 | 430 | 12 | 5 | 38172120 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.12e-06 | 605 | 12 | 5 | 28977666 | |
| Pubmed | 2.01e-06 | 74 | 12 | 3 | 33989516 | ||
| Pubmed | 6.45e-06 | 109 | 12 | 3 | 29511296 | ||
| Pubmed | 9.70e-06 | 421 | 12 | 4 | 34650049 | ||
| Pubmed | 1.12e-05 | 131 | 12 | 3 | 34551306 | ||
| Pubmed | 1.25e-05 | 136 | 12 | 3 | 26979993 | ||
| Pubmed | 1.25e-05 | 136 | 12 | 3 | 21280222 | ||
| Pubmed | 1.31e-05 | 16 | 12 | 2 | 31823782 | ||
| Pubmed | 1.35e-05 | 1007 | 12 | 5 | 34597346 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 1.40e-05 | 462 | 12 | 4 | 31138677 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.46e-05 | 1024 | 12 | 5 | 24711643 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.91e-05 | 1082 | 12 | 5 | 38697112 | |
| Pubmed | 2.28e-05 | 21 | 12 | 2 | 24923560 | ||
| Pubmed | 2.59e-05 | 1153 | 12 | 5 | 29845934 | ||
| Pubmed | 2.79e-05 | 551 | 12 | 4 | 34728620 | ||
| Pubmed | 3.25e-05 | 187 | 12 | 3 | 29777862 | ||
| Pubmed | 3.53e-05 | 26 | 12 | 2 | 27542691 | ||
| Pubmed | 4.09e-05 | 202 | 12 | 3 | 24639526 | ||
| Pubmed | 4.28e-05 | 615 | 12 | 4 | 31048545 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 4.59e-05 | 626 | 12 | 4 | 33644029 | |
| Pubmed | 5.38e-05 | 32 | 12 | 2 | 36252997 | ||
| Pubmed | 5.48e-05 | 223 | 12 | 3 | 33731348 | ||
| Pubmed | 5.48e-05 | 223 | 12 | 3 | 30572598 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 5.57e-05 | 1353 | 12 | 5 | 29467282 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 6.17e-05 | 232 | 12 | 3 | 25515538 | |
| Pubmed | 6.33e-05 | 234 | 12 | 3 | 36243803 | ||
| Pubmed | 6.49e-05 | 236 | 12 | 3 | 36339263 | ||
| Pubmed | 6.83e-05 | 36 | 12 | 2 | 24147044 | ||
| Pubmed | 7.16e-05 | 244 | 12 | 3 | 29884807 | ||
| Pubmed | 7.25e-05 | 245 | 12 | 3 | 35652658 | ||
| Pubmed | 7.61e-05 | 713 | 12 | 4 | 29802200 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 8.07e-05 | 724 | 12 | 4 | 36232890 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 8.26e-05 | 256 | 12 | 3 | 32698014 | |
| Pubmed | 8.38e-05 | 731 | 12 | 4 | 29298432 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 8.45e-05 | 258 | 12 | 3 | 37794589 | |
| Pubmed | Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. | 8.45e-05 | 40 | 12 | 2 | 23825951 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 8.55e-05 | 259 | 12 | 3 | 30404004 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 9.04e-05 | 264 | 12 | 3 | 32814769 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 9.46e-05 | 268 | 12 | 3 | 33024031 | |
| Pubmed | 1.01e-04 | 274 | 12 | 3 | 34244482 | ||
| Pubmed | 1.02e-04 | 44 | 12 | 2 | 26471122 | ||
| Pubmed | 1.12e-04 | 46 | 12 | 2 | 19928837 | ||
| Pubmed | 1.15e-04 | 286 | 12 | 3 | 32041737 | ||
| Pubmed | 1.17e-04 | 288 | 12 | 3 | 38496616 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.23e-04 | 807 | 12 | 4 | 22681889 | |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.29e-04 | 298 | 12 | 3 | 32353859 | |
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 1.43e-04 | 52 | 12 | 2 | 24591637 | |
| Pubmed | 1.46e-04 | 844 | 12 | 4 | 25963833 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.75e-04 | 330 | 12 | 3 | 33301849 | |
| Pubmed | 1.75e-04 | 330 | 12 | 3 | 32529326 | ||
| Pubmed | 2.01e-04 | 346 | 12 | 3 | 25324306 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 2.13e-04 | 353 | 12 | 3 | 27545878 | |
| Pubmed | 2.24e-04 | 65 | 12 | 2 | 34431227 | ||
| Pubmed | 2.24e-04 | 65 | 12 | 2 | 28276505 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.28e-04 | 361 | 12 | 3 | 30344098 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.34e-04 | 954 | 12 | 4 | 36373674 | |
| Pubmed | 2.71e-04 | 383 | 12 | 3 | 29331416 | ||
| Pubmed | 2.86e-04 | 390 | 12 | 3 | 17643375 | ||
| Pubmed | 3.05e-04 | 399 | 12 | 3 | 35987950 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 3.08e-04 | 400 | 12 | 3 | 35013556 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.33e-04 | 411 | 12 | 3 | 35182466 | |
| Interaction | BTRC interactions | 2.40e-06 | 775 | 12 | 6 | int:BTRC | |
| Interaction | FUS interactions | 4.69e-05 | 757 | 12 | 5 | int:FUS | |
| Interaction | CHD3 interactions | 4.69e-05 | 757 | 12 | 5 | int:CHD3 | |
| Interaction | PARP1 interactions | 5.03e-05 | 1316 | 12 | 6 | int:PARP1 | |
| Interaction | ARAF interactions | 5.24e-05 | 376 | 12 | 4 | int:ARAF | |
| Interaction | KHDRBS2 interactions | 5.40e-05 | 129 | 12 | 3 | int:KHDRBS2 | |
| Interaction | MYCN interactions | 6.39e-05 | 1373 | 12 | 6 | int:MYCN | |
| Interaction | SNIP1 interactions | 7.84e-05 | 417 | 12 | 4 | int:SNIP1 | |
| Interaction | TRIM31 interactions | 1.09e-04 | 454 | 12 | 4 | int:TRIM31 | |
| Interaction | EWSR1 interactions | 1.10e-04 | 906 | 12 | 5 | int:EWSR1 | |
| Interaction | HEXIM1 interactions | 1.15e-04 | 913 | 12 | 5 | int:HEXIM1 | |
| Interaction | AR interactions | 1.70e-04 | 992 | 12 | 5 | int:AR | |
| Interaction | PABPN1 interactions | 1.76e-04 | 192 | 12 | 3 | int:PABPN1 | |
| Interaction | RBM45 interactions | 2.19e-04 | 207 | 12 | 3 | int:RBM45 | |
| Interaction | OAZ1 interactions | 2.26e-04 | 38 | 12 | 2 | int:OAZ1 | |
| Interaction | LINC00624 interactions | 2.38e-04 | 39 | 12 | 2 | int:LINC00624 | |
| Interaction | ALDH1L2 interactions | 2.76e-04 | 42 | 12 | 2 | int:ALDH1L2 | |
| Interaction | ACE2 interactions | 2.82e-04 | 1106 | 12 | 5 | int:ACE2 | |
| Interaction | FOXC1 interactions | 2.92e-04 | 228 | 12 | 3 | int:FOXC1 | |
| Interaction | LGALS9 interactions | 2.95e-04 | 588 | 12 | 4 | int:LGALS9 | |
| Interaction | CUL2 interactions | 3.00e-04 | 591 | 12 | 4 | int:CUL2 | |
| Interaction | LMNB1 interactions | 3.39e-04 | 610 | 12 | 4 | int:LMNB1 | |
| Interaction | IRF9 interactions | 3.46e-04 | 47 | 12 | 2 | int:IRF9 | |
| Interaction | GGH interactions | 3.51e-04 | 243 | 12 | 3 | int:GGH | |
| Interaction | PAGE4 interactions | 3.96e-04 | 253 | 12 | 3 | int:PAGE4 | |
| Interaction | C1QTNF9B interactions | 4.08e-04 | 51 | 12 | 2 | int:C1QTNF9B | |
| Interaction | LSM14A interactions | 4.28e-04 | 260 | 12 | 3 | int:LSM14A | |
| Interaction | DDX3X interactions | 4.34e-04 | 651 | 12 | 4 | int:DDX3X | |
| Interaction | LGR4 interactions | 4.38e-04 | 262 | 12 | 3 | int:LGR4 | |
| Interaction | MATR3 interactions | 4.44e-04 | 655 | 12 | 4 | int:MATR3 | |
| Interaction | CCDC8 interactions | 4.47e-04 | 656 | 12 | 4 | int:CCDC8 | |
| Interaction | TRGV3 interactions | 4.74e-04 | 55 | 12 | 2 | int:TRGV3 | |
| Interaction | NSD2 interactions | 5.21e-04 | 278 | 12 | 3 | int:NSD2 | |
| Interaction | MECP2 interactions | 5.71e-04 | 1287 | 12 | 5 | int:MECP2 | |
| Interaction | CHMP4B interactions | 6.59e-04 | 727 | 12 | 4 | int:CHMP4B | |
| Interaction | CCAT1 interactions | 6.62e-04 | 65 | 12 | 2 | int:CCAT1 | |
| Interaction | PPP1CC interactions | 6.98e-04 | 738 | 12 | 4 | int:PPP1CC | |
| Interaction | MIR138-1 interactions | 7.24e-04 | 68 | 12 | 2 | int:MIR138-1 | |
| Interaction | RRP1B interactions | 7.43e-04 | 314 | 12 | 3 | int:RRP1B | |
| Interaction | MIR9-3 interactions | 7.67e-04 | 70 | 12 | 2 | int:MIR9-3 | |
| Interaction | MIR140 interactions | 7.89e-04 | 71 | 12 | 2 | int:MIR140 | |
| Interaction | GLDC interactions | 7.92e-04 | 321 | 12 | 3 | int:GLDC | |
| Interaction | MIR29B1 interactions | 8.34e-04 | 73 | 12 | 2 | int:MIR29B1 | |
| Interaction | MIR18A interactions | 8.34e-04 | 73 | 12 | 2 | int:MIR18A | |
| Interaction | MIR20A interactions | 8.57e-04 | 74 | 12 | 2 | int:MIR20A | |
| Interaction | MIR15A interactions | 8.80e-04 | 75 | 12 | 2 | int:MIR15A | |
| Interaction | FAF1 interactions | 8.88e-04 | 334 | 12 | 3 | int:FAF1 | |
| Interaction | MIR16-1 interactions | 9.04e-04 | 76 | 12 | 2 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 9.04e-04 | 76 | 12 | 2 | int:MIR199A2 | |
| Interaction | MIR7-3 interactions | 9.04e-04 | 76 | 12 | 2 | int:MIR7-3 | |
| Interaction | MIR9-2 interactions | 9.28e-04 | 77 | 12 | 2 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 9.28e-04 | 77 | 12 | 2 | int:MIR200A | |
| Interaction | BTF3 interactions | 9.41e-04 | 799 | 12 | 4 | int:BTF3 | |
| Interaction | VCP interactions | 9.42e-04 | 1435 | 12 | 5 | int:VCP | |
| Interaction | MIR98 interactions | 9.52e-04 | 78 | 12 | 2 | int:MIR98 | |
| Interaction | MIR222 interactions | 9.76e-04 | 79 | 12 | 2 | int:MIR222 | |
| Interaction | MIR1-2 interactions | 9.76e-04 | 79 | 12 | 2 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 9.76e-04 | 79 | 12 | 2 | int:MIR34C | |
| Interaction | FBP1 interactions | 1.00e-03 | 348 | 12 | 3 | int:FBP1 | |
| Interaction | MIR143 interactions | 1.00e-03 | 80 | 12 | 2 | int:MIR143 | |
| Interaction | MIR145 interactions | 1.03e-03 | 81 | 12 | 2 | int:MIR145 | |
| Interaction | MIR10B interactions | 1.05e-03 | 82 | 12 | 2 | int:MIR10B | |
| Interaction | MIR106A interactions | 1.08e-03 | 83 | 12 | 2 | int:MIR106A | |
| Interaction | MIR31 interactions | 1.10e-03 | 84 | 12 | 2 | int:MIR31 | |
| Interaction | MIR199A1 interactions | 1.10e-03 | 84 | 12 | 2 | int:MIR199A1 | |
| Interaction | MIR200B interactions | 1.10e-03 | 84 | 12 | 2 | int:MIR200B | |
| Interaction | MIR7-2 interactions | 1.10e-03 | 84 | 12 | 2 | int:MIR7-2 | |
| Interaction | MEX3C interactions | 1.10e-03 | 84 | 12 | 2 | int:MEX3C | |
| Interaction | MIR16-2 interactions | 1.13e-03 | 85 | 12 | 2 | int:MIR16-2 | |
| Interaction | MIR107 interactions | 1.13e-03 | 85 | 12 | 2 | int:MIR107 | |
| Interaction | MIR17 interactions | 1.13e-03 | 85 | 12 | 2 | int:MIR17 | |
| Interaction | MIR18B interactions | 1.13e-03 | 85 | 12 | 2 | int:MIR18B | |
| Interaction | MIR93 interactions | 1.13e-03 | 85 | 12 | 2 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 1.13e-03 | 85 | 12 | 2 | int:MIR9-1 | |
| Interaction | WWP2 interactions | 1.13e-03 | 840 | 12 | 4 | int:WWP2 | |
| Interaction | MIR20B interactions | 1.16e-03 | 86 | 12 | 2 | int:MIR20B | |
| Interaction | SIRPD interactions | 1.16e-03 | 86 | 12 | 2 | int:SIRPD | |
| Interaction | MIR29A interactions | 1.18e-03 | 87 | 12 | 2 | int:MIR29A | |
| Interaction | DROSHA interactions | 1.18e-03 | 87 | 12 | 2 | int:DROSHA | |
| Interaction | PUF60 interactions | 1.18e-03 | 369 | 12 | 3 | int:PUF60 | |
| Interaction | MIR141 interactions | 1.21e-03 | 88 | 12 | 2 | int:MIR141 | |
| Interaction | MIR29C interactions | 1.24e-03 | 89 | 12 | 2 | int:MIR29C | |
| Interaction | AATF interactions | 1.25e-03 | 376 | 12 | 3 | int:AATF | |
| Interaction | MIR221 interactions | 1.26e-03 | 90 | 12 | 2 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 1.26e-03 | 90 | 12 | 2 | int:MIR92A2 | |
| Interaction | MIR200C interactions | 1.29e-03 | 91 | 12 | 2 | int:MIR200C | |
| Interaction | MIR155 interactions | 1.32e-03 | 92 | 12 | 2 | int:MIR155 | |
| Coexpression | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP | 5.95e-05 | 173 | 12 | 3 | M2480 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN | 9.02e-05 | 199 | 12 | 3 | M3750 | |
| Coexpression | GSE17721_0.5H_VS_12H_LPS_BMDC_DN | 9.02e-05 | 199 | 12 | 3 | M4069 | |
| Coexpression | GSE17721_CTRL_VS_LPS_6H_BMDC_DN | 9.02e-05 | 199 | 12 | 3 | M3692 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN | 9.15e-05 | 200 | 12 | 3 | M3742 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.85e-05 | 200 | 12 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.64e-04 | 107 | 12 | 2 | 60b272f5c89bea8a2714f870e18b7ac89a4a4bf6 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.64e-04 | 107 | 12 | 2 | c41bc8810df67158f0ae9f6015c965a8ebd96965 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-04 | 160 | 12 | 2 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.20e-04 | 161 | 12 | 2 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.72e-04 | 166 | 12 | 2 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.72e-04 | 166 | 12 | 2 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.82e-04 | 167 | 12 | 2 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-04 | 168 | 12 | 2 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.93e-04 | 168 | 12 | 2 | d8f485f8459532a2cb0bef899e6569142cf75685 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-04 | 168 | 12 | 2 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-04 | 169 | 12 | 2 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-04 | 169 | 12 | 2 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-04 | 169 | 12 | 2 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-04 | 169 | 12 | 2 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-04 | 169 | 12 | 2 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.14e-04 | 170 | 12 | 2 | 6af7dee9b8298d4499e05a82cf9cdfe3bd81d384 | |
| ToppCell | tumor_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 9.46e-04 | 173 | 12 | 2 | 934550c0290fb1058f353d97dba92757aeb2075e | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-04 | 175 | 12 | 2 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.90e-04 | 177 | 12 | 2 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.00e-03 | 178 | 12 | 2 | 8591a40fced747ac16b3e8ebc7a22dfb3ad76da2 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 178 | 12 | 2 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-03 | 179 | 12 | 2 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-03 | 180 | 12 | 2 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-03 | 180 | 12 | 2 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-03 | 181 | 12 | 2 | a8e9ea73c24109a5d4d28bc0577cc869ad932a4d | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-03 | 181 | 12 | 2 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.05e-03 | 182 | 12 | 2 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-03 | 182 | 12 | 2 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-03 | 182 | 12 | 2 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-03 | 183 | 12 | 2 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-03 | 184 | 12 | 2 | 9cbfb9f09476b4d09eb8f92c6f21e449dabcfa98 | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.07e-03 | 184 | 12 | 2 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-03 | 184 | 12 | 2 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-03 | 185 | 12 | 2 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-03 | 186 | 12 | 2 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 186 | 12 | 2 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-03 | 187 | 12 | 2 | fa8f221b4c2df61eadaa9c77e4cf45848b00330b | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.12e-03 | 188 | 12 | 2 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-03 | 188 | 12 | 2 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-03 | 188 | 12 | 2 | c9270517e6940e9793586f67f02431210552f278 | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 191 | 12 | 2 | 4b77abc68bd72c64e7062f9527fe9d9605289ceb | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 191 | 12 | 2 | eec14997d2bfc7e6b5a601afc43a147f6b96d668 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 191 | 12 | 2 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 191 | 12 | 2 | 1730ec5dc1cfd2f0cba7e21555641c7bce97e09d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-03 | 192 | 12 | 2 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-03 | 192 | 12 | 2 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | severe-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.16e-03 | 192 | 12 | 2 | 2e80755627d0350be8976324329e106e808d5574 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.17e-03 | 193 | 12 | 2 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-03 | 193 | 12 | 2 | 41ea268e7697101fe70d8ef1045f3a43b9311739 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.17e-03 | 193 | 12 | 2 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-03 | 193 | 12 | 2 | d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-03 | 193 | 12 | 2 | b2abe939027a69b60d83a28d4d4cc53ba1dee4c5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-03 | 193 | 12 | 2 | 87ce81ff5b27d9c4300826d76ff5a62e9c408d5d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-03 | 194 | 12 | 2 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-03 | 194 | 12 | 2 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-03 | 194 | 12 | 2 | 8f19e553f18c313c2a2ff9453884b9484b255d71 | |
| ToppCell | IPF-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.19e-03 | 194 | 12 | 2 | da3e1d39575969a069ef43e552afe94b2f441d0b | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.19e-03 | 194 | 12 | 2 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-03 | 194 | 12 | 2 | f95935153bd2c4c3c7b2b729da6f7e98b45fed79 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-03 | 194 | 12 | 2 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | 3'-Distal_airway-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-03 | 194 | 12 | 2 | f5e3e675187afb6efa774f2a8d685efcf813de82 | |
| ToppCell | 21-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 1.19e-03 | 194 | 12 | 2 | 749dd8113ef260e00facac09de9861d61725124a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-03 | 194 | 12 | 2 | 67fbb81b7d20cb63be27b2a2beea5b5689f8e08c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-03 | 195 | 12 | 2 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | Mesenchymal_cells-Endosteal_fibro.|World / Lineage and Cell class | 1.20e-03 | 195 | 12 | 2 | d53974d1866e23c894ffd492ea11d20422919b11 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-03 | 197 | 12 | 2 | b67ffd27d386c8186ef71ecdac96a462504507f0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-03 | 198 | 12 | 2 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-03 | 198 | 12 | 2 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-03 | 198 | 12 | 2 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-03 | 198 | 12 | 2 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.24e-03 | 198 | 12 | 2 | 0f1feed8a37293ae02465909f99548ab58dc7ce5 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 1.25e-03 | 199 | 12 | 2 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.25e-03 | 199 | 12 | 2 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.25e-03 | 199 | 12 | 2 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.25e-03 | 199 | 12 | 2 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 1.25e-03 | 199 | 12 | 2 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.25e-03 | 199 | 12 | 2 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | distal-2-mesenchymal-Pericyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-03 | 200 | 12 | 2 | 4ee0b2f56c2652435fa78bf6b3c90cea28df74e0 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.26e-03 | 200 | 12 | 2 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| Disease | chronotype measurement | 3.67e-03 | 882 | 11 | 3 | EFO_0008328 | |
| Disease | PR interval | 1.40e-02 | 495 | 11 | 2 | EFO_0004462 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YAHGGGGTQQDGFHF | 1786 | Q6UVK1 | |
| YNHAQHGSLEGGFGI | 396 | Q5FYB1 | |
| NGAGHKVSHFYGFGL | 466 | P29122 | |
| HYESGSGQASGFGQH | 806 | Q86YZ3 | |
| YGGAGDASSGFHGGH | 181 | P31942 | |
| HHGVGQGFSGDYSEY | 366 | Q04446 | |
| GFGGANHGGYMNAGA | 656 | Q12906 | |
| DSGFQPGGYHGGHSS | 401 | Q8NCA5 | |
| GGYQYNHSGFGQGRH | 501 | Q8NCA5 | |
| VYTFGYGQHGQLGHG | 961 | O75592 | |
| AGYQSGTHQGQFDHG | 291 | Q9Y2W1 | |
| TYAHGNGYQETGGGH | 96 | Q8ND25 | |
| GQGHGENGAFSGGYH | 41 | O43763 |